- Generic name
- Mirtazapine
- Strength
- 30 mg
- Dosage form
- Tablet
- Manufactured by
- Renata PLC.
Mitapro-30 Tablet
About Mitapro-30 Tablet
Mitapro-30 is a tablet medicine used to treat major depressive disorder. Its active ingredient is mirtazapine, and it works in the brain to support mood. It belongs to a group of medicines called atypical antidepressants, and a doctor decides whether it suits you.
There are 20 brands of Mirtazapine listed in Bangladesh. The lowest listed price is Rapine 7.5 Tablet at ৳ 6 per unit.
What is Mitapro-30 Tablet?
Mitapro-30 30 mg Tablet contains mirtazapine, an atypical antidepressant. It is prescribed for major depressive disorder. The exact way mirtazapine lifts mood is not fully understood, but it is thought to increase certain chemical messenger activity in the central nervous system by blocking particular receptors. It also has a sedative effect that some people notice. Because it can make you drowsy and affect alertness, your doctor will consider this when prescribing it and will decide the dose and how long you take it.
Uses of Mitapro-30
Mitapro-30 is used to treat major depressive disorder in adults. It is not a quick fix and is taken as part of a plan your doctor sets up. Depression can affect sleep, appetite, energy and interest in daily life, and treatment aims to ease these symptoms over time. Only a qualified doctor can confirm whether this medicine is appropriate for your situation.
How to use Mitapro-30
Take Mitapro-30 exactly as your doctor tells you. The doctor decides the dose and how long you take it, and may adjust it over time as your response is reviewed. Swallow the tablet as directed. Do not stop it suddenly or change the dose on your own, because your doctor needs to manage any change carefully. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Mitapro-30
Common side effects include dizziness, drowsiness, dry mouth, increased appetite and weight gain. Some people notice anxiety, agitation, restlessness or unusual changes in behaviour, especially early in treatment or when the dose is adjusted. Contact your doctor promptly if you feel worse, have thoughts of harming yourself, or notice severe or troubling symptoms. Do not drive or operate machinery if you feel drowsy.
Safety and precautions
Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, because this medicine needs medical advice in these situations. Do not take Mitapro-30 with a monoamine oxidase inhibitor, and tell your doctor about all other medicines you take, including those for mood, pain or infections. Avoid alcohol and diazepam while taking it. People with a known allergy to mirtazapine should not use it. Because it can cause drowsiness and affect judgment, be careful with driving and skilled tasks.
Frequently asked questions
What is Mitapro-30 used for and what kind of medicine is it?
Mitapro-30 is an atypical antidepressant containing mirtazapine. It is used to treat major depressive disorder in adults. It is a prescription medicine, so only a doctor can decide whether it is right for you and how it should be taken.
Is Mitapro-30 safe during pregnancy or breastfeeding?
Pregnancy and breastfeeding need extra care with this medicine. Tell your doctor if you are pregnant, might become pregnant, or are breastfeeding, so they can advise you. Do not start or stop it on your own; your doctor will weigh the benefits and risks for your situation.
What side effects should I watch for, and when should I call the doctor?
Watch for dizziness, drowsiness, dry mouth, increased appetite and weight gain. Call your doctor if you feel worse, notice restlessness, agitation or unusual behaviour changes, or have thoughts of harming yourself. Seek help promptly for any severe or worrying symptom.
Can I stop taking Mitapro-30 on my own?
No. Do not stop suddenly or change the dose without your doctor's advice. Your doctor will decide how long you take it and how to make any changes safely. If you have concerns about your treatment, talk to your doctor or pharmacist first.
Indications
Pharmacology
Pharmacokinetics: After oral administration of Mirtazapine tablets, the active constituent mirtazapine is rapidly and well-absorbed, reaching peak plasma levels after about 2 hours. Binding of mirtazapine to plasma proteins is approximately 85%. The mean half-life of elimination is 20-40 hours; (26 hours in males, 37 hours in females). The half-life of elimination is sufficient to justify once-a-day dosing. Mirtazapine displays linear pharmacokinetics within the recommended dose range. Mirtazapine is extensively metabolized and eliminated via the urine and faeces four days. Major pathways of biotransformation are demethylation and oxidation followed by conjugation.
Dosage & Administration
Use in children: Use in children are not recommended to Mirtazapine.
Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.
Interaction
Contraindications
Monoamine Oxidase Inhibitors: The concomitant use of Mirtazapine and a monoamine oxidase (MAO) inhibitor is contraindicated. Mirtazapine should not be used within 14 days of initiating or discontinuing therapy with a monoamine oxidase inhibitor (MAOI).
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Storage Conditions
Alternative brands of Mirtazapine
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.